Cancer Genetics, Inc.

Cancer Genetics, Inc.

Cancer Genetics, Inc.

Overview
Date Founded

1999

Headquarters

201 Route 17 North,2nd floor,Rutherford, NJ 07070

Type of Company

Public

Employees (Worldwide)

110

Industries

Medical Products & Equipment
IT Consulting & Services
Medical Support Services
Hospitals & Patient Services
Biotechnology

Company Description

Cancer Genetics, Inc. engages in the development, commercialization, and sale of molecular and biomarker-based tests and services. Through its Select One Clinical Trials program, the firm provides a range of clinical trial services for both oncology and non-oncology genetic testing such as bioinformatics, biomarker solutions, bio repository solutions, consulting, cytogenetic testing, nucleic acid extraction and purification, flow cytometry, Focus: NGS Panel, gene expression analyses, genotyping, and pharmacogenomics. The company was founded by Raju S. K. Chaganti on April 8, 1999 and is headquartered in Rutherford, NJ.

Contact Data
Trying to get in touch with decision makers at Cancer Genetics, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer, Chief Financial Officer & Chief Accounting Officer

Group Medical Director & Vice President of Hematopathology

Director, Cytogenetics

Senior Vice President, Discovery & Early Development

President, Discovery & Early Development

Head-Translational Genomics Section

Head of IT

Director, Reimbursement & Clinical Revenue Cycle Management

Senior Clinical Trials Logistics Coordinator

Board of Directors

Managing Partner & Portfolio Manager at C7 Advisors LLC

Medical Director, Debartolo Family Personalized Medicine Institute at H. Lee Moffitt Cancer Center and Research Institute, Inc.

President at Clinical Research Center of Cape Cod, Inc.

Member, Board of Directors at Cancer Genetics, Inc.

Paths to Cancer Genetics, Inc.
Potential Connections via
Relationship Science
You
Cancer Genetics, Inc.
Recent Transactions
Details Hidden

Cancer Genetics, Inc. issued . USD Common Stock - Bought Deal

Details Hidden

Interpace Biosciences, Inc. purchases Cancer Genetics, Inc. /BioPharma Business from Cancer Genetics, Inc.

Details Hidden

Cancer Genetics, Inc. issued . USD Common Stock

Transaction Advisors
Auditor

Advised onCancer Genetics, Inc. issued USD Common Stock

Underwriter

Advised onCancer Genetics, Inc. issued USD Common Stock

Investment Advisor

Advised onCancer Genetics, Inc. raised money in a private placement transaction

Chief Executive Officer

Advised onCancer Genetics, Inc. issued . USD Common Stock - Bought Deal

Legal Advisor

Advised onCancer Genetics, Inc. issued USD Common Stock

Legal Advisor

Advised onCancer Genetics, Inc. issued USD Common Stock

Advisors & Consultants
Advisor

Chief Financial & Accounting Officer at Innovate Biopharmaceuticals, Inc.

Consultant

Chief Executive Officer, President & Director at Lantern Pharma, Inc.

Publicist

Vice President at Russo Partners LLC

Key Stats and Financials As of 2019
Market Capitalization
$27.5M
Total Enterprise Value
$9.73M
Earnings Per Share
$-7.82
Revenue
$7.3M
Net Profit
$-15.1M
EBITDA
$-1.96M
EBITDAMargin
-26.78%
Total Debt
$2.47M
Total Equity
$7.38M
Enterprise Value / Sales
1.33x
TEVNet Income
-0.65x
Debt TEV
0.25x
Three Year Compounded Annual Growth Rate Of Revenue
-35.36%
Non-Profit Donations & Grants
$500 +
2018
Investors
Details Hidden

Professor at Gerstner Sloan Kettering Graduate School of Biomedical Science

Details Hidden

Equity Dynamics focuses on early-stage venture capital investments in technology, medical and healthcare companies located in the US. The firm will participate as a lead investor but this is not a requirement. They will also participate in investments with other venture capital firms.

Details Hidden

MediGen Group provides seed and early-stage capital to new life sciences companies. The firm may fund proof-of-concept experiments and deal conceptualization. Companies should have large growing markets and strong intellectual property. They should also have defined regulatory paths to accelerate product development and mitigate FDA approval risk. MediGen seeks investments in companies with a clear path to monetization with substantial short-term value-creating milestones that allow for multiple exit opportunities and hedges against developmental setbacks

Suppliers
Agilent Technologies, Inc. Hospitals & Patient Services | Santa Clara, CA

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Competitors
Laboratory Corporation of America Holdings Medical Support Services - Burlington, NC

LabCorp provides leading-edge medical laboratory tests and services through a national network of primary clinical laboratories and specialized Centers of Excellence. Recognized for our innovation, quality, and customer convenience, LabCorp delivers timely, accurate results for improved patient care. With scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, LabCorp performs more than 1 million tests on more than 370,000 specimens each day. LabCorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. LabCorp operates a sophisticated laboratory network, with corporate headquarters in Burlington, NC, and more than 30,000 employees nationwide. Our 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. Laboratory Corporation of America Holdings is listed on the New York Stock Exchange (NYSE) under ticker symbol LH

IQVIA Holdings, Inc. Medical Support Services - Durham, NC

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.

Medpace Holdings, Inc. Other Business & Consulting Services - Cincinnati, OH

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in July 1992 and is headquartered in Cincinnati, OH.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cancer Genetics, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cancer Genetics, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cancer Genetics, Inc..